Canadian Manufacturing

Duchesnay acquired by its senior management team, headed by Éric Gervais

by CM Staff   

Human Resources Manufacturing Operations Infrastructure human resources infrastructure Manufacturing personnel announcements Pharmaceutical Manufacturing

The group also includes a pharmaceutical manufacturing facility, adjoining the head office in Blainville, Quebec.

Duchesnay President Éric Gervais (CNW Group/Duchesnay inc.)

BLAINVILLE — The ownership of Duchesnay and its affiliated pharmaceutical companies, based in Blainville, Quebec, have been acquired by its senior management headed by Éric Gervais, President, after more than 25 years as Executive Vice-President. Management has acquired these successful businesses from Pierre Boivin and his family after he expressed his desire to step back to pursue other interests.

The group of companies includes: Duchesnay, based in Canada, and Duchesnay USA, both dedicated to women’s health; Médunik Canada and Medunik USA, which provide treatments for rare diseases to Canadian and American patients; and Analog Pharma, an American generic drugs company, with a focus on orphan drugs. The group also includes a pharmaceutical manufacturing facility, adjoining the head office in Blainville, Quebec.

“It is a great honour and privilege to take the helm of these pharmaceutical companies and to work alongside our dynamic leadership team of co-owners to drive the businesses to continued success in the future,” said Éric Gervais. “We look forward to continuing to bring to market innovative and affordable medications that will make a difference in patients’ lives in North America and abroad.”

The new ownership and senior management team is reportedly committed to maintaining the company’s long-held values and vision.


The transaction to transfer ownership was made possible with the participation and assistance of BDC, the Business Development Bank of Canada. “As the bank for Canadian entrepreneurs, BDC is very pleased to be supporting this transformation at Duchesnay that will help propel the company to a new level of success,” said Mark Ohannessian, Director, Growth & Transition Capital, BDC.

“We are impressed with the new owners’ vision for the future and the growth potential that Duchesnay presents. We wish them much success in this new chapter,” added Krystel Durocher, Director, Corporate Financing, at BDC in Montreal.


Stories continue below

Print this page

Related Stories